Given that ANGPTL4 has emerged as a crucial player in cancer progression, it is important to know whether ANGPTL4 undergoes the regulation of tumour radioresistance under hypoxia and how its contribution in the signalling communication within TME. This evidence concerns the gene ANGPTL4 and neoplasm.